Long-Term Mortality Following Transcatheter Atrial Septal Defects Closure in Comparison to the General Population

Sami Alnasser,Douglas S. Lee,Mark Osten,Peter C. Austin,Ashish Shah,Yvonne Bach,Lusine Abrahamyan,Bing Yu,Lee Benson,Eric M. Horlick

Journal of the American College of Cardiology（2020）

引用 1|浏览28

暂无评分

摘要

Transcatheter atrial septal defect closure (TAC) is a well-established therapy for most patients with secundum atrial septal defects (ASD) based on short-term data ([1][1]). In previous surgical studies, mortality was not significantly different from age-and-sex matched control subjects ([2][2]).

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要